Attached files
Exhibit
32.1
CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT
TO 18 U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
The
undersigned, Glynn Wilson, the Chief Executive Officer of TapImmune Inc. (the
“Company”), hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his or her
knowledge, the Annual Report on Form 10-K for the year ended December 31, 2009
fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended, and that the information contained in the
Annual Report on Form 10-K, as amended, fairly presents in all material respects
the financial condition and results of operations of the Company.
Date:
April 13, 2010
By:
/s/ Glynn
Wilson________________________
Glynn Wilson
Chairman, Chief Executive
Officer,
Principal Executive Officer and a
director